Si Chuan Venture Capital

Total investments

15

Average round size

6M

Portfolio companies

14

Rounds per year

1.67

Lead investments

4

Follow on index

0.07

Stages of investment
Early Stage Venture
Areas of investment
AutomotiveLogisticsBiotechnologyInternetSoftwareInformation TechnologyHealth CareEducationMedicalPharmaceutical

Investments analytics

Analytics

Total investments
15
Lead investments
4
Rounds per year
1.67
Follow on index
0.07
Investments by industry
  • Medical (5)
  • Pharmaceutical (4)
  • Biotechnology (4)
  • Health Care (3)
  • Automotive (2)
  • Show 24 more
Investments by region
  • China (15)
Peak activity year
2019

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
6
Group Appearance index
0.87

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
IDEATE Medical 01 Jan 2019 Health Care, Medical Device, Medical Early Stage Venture 4M
New Radiomedicine Technology 14 Mar 2024 Biotechnology, Health Care, Medical Late Stage Venture 46M Sichuan, Qingyang District, China
Spherics 17 Feb 2000 Biotechnology, Manufacturing, Pharmaceutical, Biopharma Early Stage Venture 4M United States, Massachusetts
Stork Healthcare 01 Apr 2019 Health Care, Medical Early Stage Venture Sichuan, Qingyang District, China

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.